BAC vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

BAC

50.3
AI Score
VS
CARE Wins

CARE

59.8
AI Score

Investment Advisor Scores

BAC

50score
Recommendation
HOLD

CARE

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BAC CARE Winner
Forward P/E 13.6612 13.6612 Tie
PEG Ratio 1.0755 0 Tie
Revenue Growth 16.8% 68.3% CARE
Earnings Growth 34.1% 253.9% CARE
Tradestie Score 50.3/100 59.8/100 CARE
Profit Margin 29.5% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BAC 1M: +0.7% · 3M: +19.8% CARE 1M: -7.8% · 3M: +16.0%

Current Technical Phase

BAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.6 · Price: $61.69

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.7 · Price: $31.25

Fundamentals Snapshot

Metric BAC CARE
Market Cap
Forward P/E 11.7 12.1
Trailing P/E 14.6 5.3
Revenue (TTM)
Revenue Growth 0.2% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.6%
EPS 4.24 5.80
Dividend Yield 0.02% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.